Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
BT-549
TNBC
Basal B
(Z)-4-Hydroxytamoxifen
ESR1
7804.016
uM
inf
6.52220
0.6730 0.7956 5.0000 0.0568
0.6718
2.3055
SUM149PT
TNBC
Basal B
Glycyl-H-1152
ROCK2
10819.15
uM
69.42850
464.22560
0.6339 -1.0000 0.5782 0.0678
0.9396
2.1256
SUM149PT
TNBC
Basal B
Glycyl-H-1152
ROCK2
11937.16
uM
84.87320
21.4970
0.5288 0.3549 0.9008 0.0794
0.9443
2.4144
BT-549
TNBC
Basal B
(Z)-4-Hydroxytamoxifen
ESR1
9024.016
uM
inf
5.49290
0.9158 0.9125 0.9479 0.0127
0.6896
3.2430
HCC2185
TNBC
Luminal
(Z)-4-Hydroxytamoxifen
ESR1
9420.132
uM
inf
inf
1.0500 1.0500 0.0000 0.0075
-0.0001
0.3309
BT-549
TNBC
Basal B
(Z)-4-Hydroxytamoxifen
ESR1
7803.016
uM
inf
999.99990
0.8001 0.2753 0.5655 0.0269
0.7925
2.8300
HCC38
TNBC
Basal B
Ibandronate
FDPS
11850.143
uM
58.12590
78.37930
-0.4564 -0.4499 2.1468 0.3429
0.9952
2.1044
SK-BR-3
HER2amp
Luminal
Nelfinavir
12999.174
uM
7.55250
13.51060
-0.7021 -1.0000 1.8890 0.2038
0.9850
0.8315
MDA-MB-468
TNBC
Basal A
CGC-11047
Polyamine analogue
7907.018
uM
1.07690
84.78930
-0.8313 -1.0000 0.2516 0.7516
0.8193
1.5217
CAMA-1
HR+
Luminal
Methylglyoxal
13157.184
uM
532.38820
1000.00000
-0.9916 -0.5508 1.1782 0.3945
0.8666
0.8492
HCC1806
TNBC
Basal A
Nelfinavir
12702.174
uM
8.77290
11.30080
-0.8571 -0.8812 4.0129 0.1752
0.9941
1.8506
HCC1954
HER2amp
Basal A
(Z)-4-Hydroxytamoxifen
ESR1
7836.016
uM
33.93490
143.9580
-0.0804 -1.0000 0.7602 0.1638
0.9872
1.5669
SUM149PT
TNBC
Basal B
Ibandronate
FDPS
10819.143
uM
256.9290
999.98650
0.0594 -0.6639 0.6217 0.1984
0.9772
2.2570
SUM149PT
TNBC
Basal B
Ibandronate
FDPS
11937.143
uM
263.80820
1000.00000
0.0199 -0.6889 0.6500 0.1784
0.9858
2.3169
MDA-MB-415
HR+
Luminal
Ibandronate
FDPS
10938.143
uM
46.92680
98.68990
-0.8792 -0.9200 1.4041 0.4882
0.9554
1.0173
600MPE
HR+
Luminal
Methylglyoxal
13091.184
uM
541.6520
823.99310
-0.9999 -0.9709 2.5719 0.6677
0.9952
0.8014
MDA-MB-415
HR+
Luminal
Ibandronate
FDPS
12333.143
uM
48.64890
54.3240
-0.4546 -0.3681 4.9998 0.4351
0.9371
0.6265
MCF 10A
NM
Basal B
Ribavirin
15392.211
uM
inf
1000.00000
0.6244 0.0123 0.2385 0.1289
0.6395
2.9667
HCC1143
TNBC
Basal A
Methylglyoxal
13099.184
uM
202.87190
579.86070
-0.9991 -1.0000 1.0461 0.7426
0.9727
1.0279
EFM-192C
HER2amp
Luminal
Ribavirin
15292.211
uM
inf
inf
0.6694 0.6694 0.0000 0.1738
0.0209
1.7715
MDA-MB-468
TNBC
Basal A
CGC-11047
Polyamine analogue
7904.018
uM
3.02880
158.54660
-0.7754 -1.0000 0.2776 0.6540
0.7761
1.4056
184A1
NM
Basal
Mebendazole
12684.174
uM
inf
0.36667
0.5334 0.5745 5.0000 0.1723
0.9699
1.4645
CAMA-1
HR+
Luminal
Nelfinavir
12647.174
uM
4.63860
8.64280
-0.9213 -1.0000 1.7654 0.3605
0.8914
0.9362
HCC70
TNBC
Basal A
Torkinib
15390.211
uM
-inf
0.00003
-0.9960 -0.9803 0.5245 1.8586
0.9905
0.5021
HCC1428
HR+
Luminal
(Z)-4-Hydroxytamoxifen
ESR1
9294.019
uM
0.86738
57.77570
-0.3357 -1.0000 0.2617 0.4741
0.9102
0.8608